stage 2 breast cancer recurrence rate

Release time ：Dec-24,2024

The recurrence rate for stage two breast cancer typically ranges from 20% to 30%, but it is subject to various influencing factors. Tumors that are positive for hormone receptors and negative for HER2 generally pose a lower risk of recurrence compared to those that are negative for hormone receptors and positive for HER2. Younger patients are often at a higher risk for recurrence. Genetic factors, including mutations in the BRCA genes, can also elevate the risk of recurrence. Regarding treatment, a multimodal approach (encompassing surgery, radiotherapy, chemotherapy, and endocrine therapy) is often effective in reducing the likelihood of recurrence. Nonetheless, despite optimal treatment, some patients may still face recurrence due to the presence of minimal residual disease. For those diagnosed with stage two breast cancer, it is imperative to be aware of these factors and to adhere to medical advice. Regular follow-up checks and maintaining a healthy lifestyle are also vital in mitigating the risk of recurrence. Under all circumstances, patients must adhere to their physician's guidance and refrain from unilaterally altering or discontinuing their treatment regimen.